Market Closed -
Other stock markets
|
After market 06:07:21 pm | |||
160.4 USD | -1.29% | 161.4 | +0.62% |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
May. 08 | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
ETFs positioned on AbbVie Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.72% | 0 M€ | +18.86% | - | |
0.72% | 36 M€ | +22.19% | ||
0.71% | 0 M€ | +11.74% | - | |
0.69% | 1 M€ | -.--% | ||
0.69% | 0 M€ | +12.96% | ||
0.67% | 8 M€ | +5.48% | - | |
0.66% | 0 M€ | +4.51% | - | |
0.65% | 0 M€ | +11.40% | - | |
0.62% | 414 M€ | +11.14% | - | |
0.62% | 1,006 M€ | -.--% | - | |
0.57% | 0 M€ | +17.73% | ||
0.57% | 322 M€ | +13.88% | - | |
0.57% | 29 M€ | -.--% | - | |
0.53% | 14 M€ | +16.19% | - | |
0.53% | 1 M€ | +3.03% | - | |
0.48% | 5 M€ | -.--% | - | |
0.46% | 1,166 M€ | +0.26% | - | |
0.46% | 607 M€ | +0.05% | - | |
0.46% | 0 M€ | +6.03% | - | |
0.45% | 284 M€ | -.--% | ||
0.45% | 0 M€ | +7.81% | ||
0.45% | 0 M€ | -.--% | ||
0.45% | 23 M€ | -.--% | - | |
0.45% | 786 M€ | -.--% | ||
0.44% | 0 M€ | 0.00% | - | |
0.42% | 206 M€ | -.--% | ||
0.41% | 0 M€ | +8.23% | - | |
0.41% | 0 M€ | +8.21% | - | |
0.39% | 0 M€ | +7.77% | - | |
0.37% | 0 M€ | +3.67% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 287B | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- ABBV Stock
- Funds and ETFs AbbVie Inc.